𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[Progress in Pharmaceutical and Biomedical Analysis] Identification and Determination of Impurities in Drugs Volume 4 || 9.2. Biotechnological products

✍ Scribed by Ganzler, Katalin


Book ID
120617376
Publisher
Elsevier
Year
2000
Tongue
English
Weight
1020 KB
Category
Article
ISBN
0444828990
ISSN
1464-3456

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


[Progress in Pharmaceutical and Biomedic
✍ GΓΆrΓΆg, SΓ‘ndor πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier 🌐 English βš– 92 KB

Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since thi

[Progress in Pharmaceutical and Biomedic
✍ Euerby, Melvin R. πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier 🌐 English βš– 598 KB

Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since thi

[Progress in Pharmaceutical and Biomedic
✍ Lane, Steve J. πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier 🌐 English βš– 984 KB

Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since thi

[Progress in Pharmaceutical and Biomedic
✍ LΓ‘sztity, Alexandra πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier 🌐 English βš– 571 KB

Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since thi